GR1002471B - Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν. - Google Patents

Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν.

Info

Publication number
GR1002471B
GR1002471B GR880100084A GR880100084A GR1002471B GR 1002471 B GR1002471 B GR 1002471B GR 880100084 A GR880100084 A GR 880100084A GR 880100084 A GR880100084 A GR 880100084A GR 1002471 B GR1002471 B GR 1002471B
Authority
GR
Greece
Prior art keywords
preparation
piperazinecarboxylic acid
pharmaceutical compositions
compositions containing
disorders
Prior art date
Application number
GR880100084A
Other languages
Greek (el)
English (en)
Other versions
GR880100084A (el
Inventor
Bernhard Dr. Aebischer
Original Assignee
Novartis Ag (Novartis Sa) (Novartis Inc.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag (Novartis Sa) (Novartis Inc.) filed Critical Novartis Ag (Novartis Sa) (Novartis Inc.)
Publication of GR880100084A publication Critical patent/GR880100084A/el
Publication of GR1002471B publication Critical patent/GR1002471B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR880100084A 1987-02-18 1988-02-16 Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν. GR1002471B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (2)

Publication Number Publication Date
GR880100084A GR880100084A (el) 1988-12-16
GR1002471B true GR1002471B (el) 1996-11-15

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100084A GR1002471B (el) 1987-02-18 1988-02-16 Πιπεραζινκαρβοξυλικο οξυ,η παρασκευη του και φαρμακευτικες συνθεσεις που το περιεχουν.

Country Status (28)

Country Link
JP (1) JPH0723387B2 (fr)
KR (1) KR960015190B1 (fr)
AT (1) AT391320B (fr)
AU (1) AU613009B2 (fr)
BE (1) BE1002427A3 (fr)
CA (1) CA1327799C (fr)
CH (1) CH675125A5 (fr)
CY (1) CY1739A (fr)
DE (1) DE3804936C2 (fr)
DK (1) DK168441B1 (fr)
ES (2) ES2011319A6 (fr)
FI (1) FI86733C (fr)
FR (1) FR2610932B1 (fr)
GB (2) GB8703749D0 (fr)
GR (1) GR1002471B (fr)
HK (1) HK142093A (fr)
HU (2) HU199858B (fr)
IE (1) IE59098B1 (fr)
IL (1) IL85436A0 (fr)
IT (1) IT1219447B (fr)
LU (1) LU87129A1 (fr)
MY (1) MY103206A (fr)
NL (1) NL8800412A (fr)
NZ (1) NZ223529A (fr)
PH (1) PH25512A (fr)
PT (1) PT86776B (fr)
SE (1) SE467256B (fr)
ZA (1) ZA881146B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
EP0826032A1 (fr) * 1995-05-08 1998-03-04 Lonza Ag PROCEDE BIOTECHNOLOGIQUE DE PRODUCTION D'ACIDE R-$g(a)-CARBOXYLIQUE DE PIPERAZINE ET D'AMIDE D'ACIDE S-$g(a)-CARBOXYLIQUE DE PIPERAZINE
HUP0100048A3 (en) 1997-05-12 2002-12-28 Ortho Mcneil Pharm Inc Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (fr) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probénécide destiné à être utilisé dans le traitement de maladies, troubles ou états épileptiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques

Also Published As

Publication number Publication date
IT8847631A0 (it) 1988-02-12
JPH0723387B2 (ja) 1995-03-15
ZA881146B (en) 1989-10-25
GB2201676B (en) 1991-01-02
KR880009944A (ko) 1988-10-06
DK168441B1 (da) 1994-03-28
FI86733B (fi) 1992-06-30
AT391320B (de) 1990-09-25
JPS63203691A (ja) 1988-08-23
GB8703749D0 (en) 1987-03-25
LU87129A1 (fr) 1988-09-20
PH25512A (en) 1991-07-24
DE3804936C2 (de) 1997-02-13
CA1327799C (fr) 1994-03-15
DK79688A (da) 1988-08-19
FR2610932A1 (fr) 1988-08-19
ES2011319A6 (es) 1990-01-01
IL85436A (fr) 1992-12-01
DE3804936A1 (de) 1988-09-01
SE8800541D0 (sv) 1988-02-17
ES2021904A6 (es) 1991-11-16
FI880744A (fi) 1988-08-19
BE1002427A3 (fr) 1991-02-05
GB8803438D0 (en) 1988-03-16
HU199858B (en) 1990-03-28
DK79688D0 (da) 1988-02-16
SE467256B (sv) 1992-06-22
HU211269A9 (en) 1995-11-28
SE8800541A (fr) 1988-08-19
AU1175888A (en) 1988-08-25
CY1739A (en) 1995-10-20
NZ223529A (en) 1991-02-26
IL85436A0 (en) 1988-07-31
IT1219447B (it) 1990-05-18
NL8800412A (nl) 1988-09-16
CH675125A5 (fr) 1990-08-31
FI86733C (fi) 1992-10-12
PT86776A (pt) 1988-03-01
HK142093A (en) 1994-01-07
IE59098B1 (en) 1994-01-12
ATA36788A (de) 1990-03-15
FI880744A0 (fi) 1988-02-17
MY103206A (en) 1993-05-29
PT86776B (pt) 1992-05-29
GR880100084A (el) 1988-12-16
KR960015190B1 (ko) 1996-11-01
IE880413L (en) 1988-08-18
AU613009B2 (en) 1991-07-25
FR2610932B1 (fr) 1990-11-16
GB2201676A (en) 1988-09-07
HUT49361A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
GB2208476B (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
KR100521829B1 (en) Compositions and Methods for the Treatment of Alzheimer's Disease, Central Nervous System Injury, and Inflammatory Diseases
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
HUP0100786A3 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
MY103206A (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
AU642428B2 (en) Method of treatment of CNS disorders and /or pain using gamma aminobutyric acid autoreceptor antagonists
WO2003066071A8 (fr) Formulations comprenant des medicaments psychotropes et du selenium
HUT65369A (en) Bcrf1 proteins as inhibitors of gamma-interferon
EP0383171A3 (fr) Dérivés de 2,3,23 trihydroxy-urs-12-ène pour le traitement des troubles cognitifs
EP0435177A3 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
HK1047549A1 (en) Il6ril6 chimera for the treatment of neurodegeneraive diseases.
EP0273310A3 (fr) 5-Aryl-3H-1,2,4-triazol-3-ones et leur emploi comme anticonvulsifs
MY105555A (en) Heterocyclicguanidines as 5ht 3 antagonists.
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
PL285854A1 (en) Therapeutical device, especially for treatment of sexual disorders in men
ZA884835B (en) Treatment of cerebral disorders
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ZA859695B (en) 2-(arylalkyloxymethyl)morpholine,preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system
IL124730A0 (en) Compositions comprising bismuth and one or more antimicrobials for the prevention and treatment of gastrointestinal disorders
IL124729A (en) Use of bismuth for the manufacture of compositions for the treatment and prevention of gastrointestinal disorders
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
ZA879420B (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees